Organization and Significant Accounting Policies (Details Narrative) - USD ($)		1 Months Ended					12 Months Ended
	Jan. 09, 2017	Mar. 01, 2017	Dec. 01, 2016	Sep. 01, 2016	Jun. 01, 2016	May 12, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2018	Sep. 29, 2014
Services Agreement, Sales and Marketing Services Fee Percentage								20.00%
Services Agreement, Sales and Marketing Services Fee Percentage after Third Anniversary								10.00%
Intangible Assets, Net (Excluding Goodwill)								$ 0	$ 2,215,385
Capitalized Computer Software, Net								700,000	1,700,000
Advertising Expense								$ 74,916	$ 69,091
Share-based Compensation Arrangement by Share-based Payment Award, Estimated Forfeiture Rate								8.10%	7.00%
Deconsolidation, Gain (Loss), Amount								$ (2,785,910)	$ 0
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 1.75
Restructuring Charges								$ 100,000
Scenario, Forecast [Member]
Services Agreement, Sales and Marketing Services Fee Income							$ 100,000
Noncontrolling Interest, Ownership Percentage by Parent										25.00%
Minimum [Member]
Fair Value Inputs, Discount Rate								30.00%
Maximum [Member]
Fair Value Inputs, Discount Rate								50.00%
Subsequent Event [Member]
Debt Instrument, Periodic Payment, Interest	$ 106,250
Debt Instrument, Periodic Payment, Principal	265,625
Wavi Holdings AG [Member]
Proceeds from Lines of Credit			$ 1,000,000	$ 1,000,000	$ 1,000,000			$ 3,000,000
Line of Credit Facility, Maximum Borrowing Capacity						$ 4,000,000
Line of Credit Facility, Interest Rate During Period						10.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						550,000
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 1.75
Line of Credit Facility, Expiration Date						Jun. 01, 2017
Warrants Expiration Date						May 12, 2021
Line of Credit Facility, Description						Under the related commitment letter, WAVI has agreed to make a series of four $1 million advances on June 1, 2016, September 1, 2016, December 1, 2016 and March 1, 2017.
Wavi Holdings AG [Member] | Subsequent Event [Member]
Proceeds from Lines of Credit		$ 1,000,000
Debt Instrument, Periodic Payment, Principal	$ 4,000,000
Line of Credit Facility, Interest Rate During Period	10.00%
Debt Instrument, Maturity Date	Jun. 01, 2022
Wavi Holdings AG [Member] | Amended and Restated Promissory Note [Member] | Subsequent Event [Member]
Debt Instrument, Periodic Payment, Interest	$ 106,250
Debt Instrument, Periodic Payment, Principal	$ 265,625
Debt Instrument, Maturity Date	Jun. 01, 2022
Debt Instrument, Description	beginning September 1, 2017 to June 1, 2018, the Company will make four quarterly cash interest only payments of $106,250 and from September 1, 2018 through June 1, 2022, the Company will make quarterly cash principal payments of $265,625
Restated Biologistex Operating Agreement [Member]
Equity Method Investment, Ownership Percentage											60.00%
Biologistex [Member]
Long-term Line of Credit								$ 6,557,776
Noncontrolling Interest, Description								(i) on the first anniversary of the Closing Date, 11.11% of its membership interest in biologistex owned as of the Closing Date, such that on the first anniversary of the Closing Date the Company will own 40% of biologistex (assuming that there are no other issuances or transfers of biologistex equity interests after the Closing Date), and (ii) on the second anniversary of the Closing Date, 33.33% of its membership interest in biologistex owned as of the Closing Date, such that on thesecond anniversary of the Closing Date the Company will own 25% of biologistex (assuming that there are no other issuances or transfers of biologistex equity interests after the Closing Date). However, if certain liquidity events, such as change in control or initial public offering, occur with respect to biologistex between the second anniversary and third anniversary of the Closing Date, STLLC will pay to the Company an amount of the net proceeds therefrom as if the Company had only transferred to STLLC on the second anniversary of the Closing Date an amount of membership interests in biologistex equal to 11.11% of the Companys membership interest in biologistex owned as of the Closing Date, such that the Company would be treated for such purposes as if it owned 35% of biologistex (assuming that there are no other issuances or transfers of biologistex equity interests after the Closing Date).
Parent Company [Member] | Biologistex [Member]
Noncontrolling Interest, Ownership Percentage by Parent								55.00%
Savsu [Member]
Equity Method Investment, Ownership Percentage											52.00%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners											48.00%
Equity Method Investment, Summarized Financial Information, Current Assets								$ 500,000
Equity Method Investment, Summarized Financial Information, Assets								$ 3,200,000
Savsu [Member] | Restated Biologistex Operating Agreement [Member]
Equity Method Investment, Ownership Percentage								45.00%
Savsu [Member] | Biologistex [Member]
Decrease in Ownership Percentage								7.00%
Biologistex Joint Venture [Member]
Gain on Derecognizing Assets, Liability and Equity								$ 2,200,000
Deconsolidation, Gain (Loss), Amount								(2,800,000)
Deconsolidation, Revaluation of Retained Investment, Gain (Loss), Amount								$ (5,000,000)
Custmer One [Member]
Revenue from customers located in foreign countries								17.00%	21.00%
Concentration Risk, Percentage								12.00%	10.00%
Three Customer [Member]
Concentration Risk, Percentage								45.00%	53.00%